tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





Get advice about BPS Bioscience

BPS Bioscience

BPS Bioscience - tebu-bio
BPS Bioscience is leading producer of recombinant enzymes (wild-type and mutants), assay kits, substrates, and services for Drug Discovery. BPS Bioscience manufactures one of the largest selections of druggable targets (Acetyltransferases, HDACs, Histone Demethylases, Histone Methyltransferases, Kinases, Peptidases, Phosphatases, Phosphodiesterases, Poly ADP Ribose Polymerases, Ubiquitin Enzymes...).

Recently, assays to investigate immuno checkpoint protein interactions in relation to immunotherapy drug discovery programs have been added to the portfolio of products and services (e.g. PD-1/PD-L1/PD-L2;  B7-1/CD28, B7-1/CTLA4;  BLTA/HVEM, CD47/SIRPα; GITR/GITRL; CD47:SIRPα; CD137:CD137L; CD40:CD40L; TIGIT/CD226 as well as the Trp catabolism pathway (IDO and TDO)). 


Their expanding offer is available in Europe via tebu-bio. For advice on choosing your BPS products, get in touch with your local tebu-bio office.

Find your BPS Bioscience products below or contact your tebu-bio local office.

Split per category

Antibodies

Primary Antibodies

Assays & Kits

Cell Based Assays Functional Assays Support Products

Cells, Media & Fractions

Primary Cells Media & ECM Cell Lines Support Products

Genomics

Enzymes Cloning Tools

Lab Consumables

Buffers

Lipidomics

Lipids

Molecules

Inhibitors & Activators Chemicals Labelling Substrates

Proteins & Peptides

Peptides Proteins

Others

21 blog articles

2 webpages

21 blog articles


IDO/TDO enzymatic pathway as an additional target for Cancer Drug Discovery | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

drug discovery | tebu-bio's blog - Part 3 Facebook Google+ LinkedIn Twitter YouTube

New Reporter cell lines for Drug discovery and Immunotherapy checkpoint research | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

10 Human Immune Checkpoint biomarkers quantified simultaneously | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

CAR T-Cell therapy: new hope for Immunotherapy and Cancer treatment | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Cell-based assay to discover new immuno-oncology treatments | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

drug discovery | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

New Continued use immunotherapy cell line expressing recombinant PD-1 | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

cancer | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Versatile method to detect luciferase in reporter cell lines | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

How to easily screen adenosine A2AR agonists and antagonists? | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

IL-17A pathway a key target for immunotherapies | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Screen for inhibitors of PD-1 signalling with a complete cellular assay system | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Measure Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Immunotherapy Screening B7-1 / CD28 and B7-1 / CTLA4 Pathways in Drug Discovery | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

New FcGR2B cell line: Boost your Immunotherapeutic antibody development | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

HDACs: Active drug targets for Immunotherapy treatment | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

New FcGR2B cell line: Boost your Immunotherapeutic antibody development | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

How to improve your reporter gene assays? | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

9 pathway-specific screening assays in Immunotherapy | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Cell-based assay to discover new immuno-oncology treatments | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

2 Webpages